Radiation therapy or also known as radiotherapy is a standard treatment method for cancer, along with surgery and chemotherapy. Currently, it is utilized to cure localized solid tumors like breast cancer, skin cancer and even cervical cancer. It may as well be utilized for lymphoma and leukemia treatment

Radiotherapy causes cancerous cells the inability to develop and multiply by ruining the DNA structure located in these cancerous cells. Radiation exposure is applied with the hope of eradicating the cancer and curing the disease. The procedure of radiotherapy itself is intended to target cancer cells, there is a possibility that healthy cells adjacent the tumor becoming affected by the exposure thus causing damages to these healthy cells. The basic technique of radiotherapy is to optimize tumor cell radiation exposure while minimizing the exposure to healthy cells. When healthy cells are exposed to radiation, it may cause several adverse effects. The progress and development radiotherapy is limited due to these negative side effects. Although, there are other types of radiotherapy which results in minimal harm to the healthy tissue surrounding the tumor since they are quite focused to the cancer. These types of sophisticated radiotherapy include proton therapy and Cyber Knife therapy.

The success of radiotherapy increases with the use of radiosensitizers and radioprotectors. Several substances that are rediosensitizers include green tea, curcumin, genistein and even hyperthermia. On the other hand, substances that are considered to be radioprotectors include glutathione, shark oil, whey protein, and ginseng. Radiotherapy is a very detailed and intricate procedure which requires thorough preparation since the success of radiotherapy also depends on specific drugs, technical approaches and nutritional supplements. These additional factors can help improving and even curing side effects brought forth by radiotherapy exposure.

Radiotherapy is included in a standard package protocol with surgery and chemotherapy since there isn’t any form of cancer therapy that can ultimately and successfully treat cancer patients with solid tumors. Another form of radiotherapy is ion radiation which forms ions when radiation travels through the affected tissue. Basically, ions are considered as atoms which obtain electrical charges when it loses or receives an electron. Subsequently, these ions can directly or indirectly cause cell damage and even genetic changes. These direct results include molecular structure changes of essential molecules such as the DNA.

Indirect results of radiotherapy happen when radiation reacts with water molecules located inside cells which produces highly reactive unstable free radicals. These free radicals immediately interact with bimolecular material located nearby. The subsequent damage will cause cell death initiated by two basic mechanisms. Firstly of all, is a process called apoptosis which can cause cell death in just several hours of radiation exposure. The second process causes disruption in cell division due to radiation exposure and subsequently blocks cellular proliferation leading to the death of cells. Located inside the cells are several non-enzymatic and enzymatic antioxidant mechanisms which manage further damage or destruction by scavenging reactive oxygen groups.

This information may be confusion for patients planning to undergo radiotherapy. It is wise to always consult a physician for further questions on any aspect of radiotherapy especially about its side effects. With enough knowledge and understanding about this treatment method, it is possible to undergo radiotherapy with ease and without any complications.

When Rontgen and Becquerel discovered radiation and x – rays during the late 1800s it stimulated the development and research for radiation application. Also, during the turn of the century, Marie Curie received a Nobel Prize for her work and research on radioactive elements.

Coincidently, based on several studies at that time, physicians and scientist discovered that radiation exposure slowed and regressed the development of several cancerous tumors. At that time experts could not find the cause of this phenomena even though based on historical data, the first oncologist treated successfully the first cancer patient in 1898. During this early era of radiotherapy, it was mainly used to treat superficial types of cancer. Interestingly enough, most cancer cases treated at this time had a tendency to reoccur due to the inconsistent specification of radiation application procedures and the huge doses of radiation the patient was exposed to.

The development of radiotherapy continued throughout that late 1930s until the late 1940s when the enhanced development of hardware allowed propelling charged particles via a vacuum tunnel known as a linear accelerator or Linac for short. This development was utilized to create an extremely penetrable beam to focus radiation onto cancerous tumors deeper within the body while limiting its effect towards the skin. Edward Ginzton and Dr. Henry Kaplan, two experts for Stanford University, collaborated to implement a standard operational procedure which could be used safely in a clinical setting. By the year 1960, the research of these experts resulted in the first publically used rotational radiotherapy Linac known as the Clinac 6. On the other hand, when Clinca 6 was introduced, an enhanced powered x – ray projection machine system was readily available to a certain radiation oncologist. Although, flaws in this machine system included limited ability to direct the charged particles and locating the main tumor.

The past few decades the development and advances of radiotherapy technology have been amazing even though there have been several limitations. One main problem in the development of radiotherapy hardware technology was to prevent or limit the exposure of healthy cells to radiation. It was essential to create a more precise targeting method and the charged particles were required to consistently form the shape of the cancerous tumor. With the further development of computer technology, this has allowed physicians to obtain three dimensional scans of the tumor and surrounding tissues.

The combination of radiotherapy and advanced mapping methods of internal scanning technology resulted in the Intensity – modulated radiation therapy also known as IMRT machine. This machine integrates mapping data and information from devices which are capable of performing Computer Tomography (CT) scans. The procedures above results in a detailed three dimensional image of the tumor which is then sent to the radiation beam Linac system to focus on the contours of the tumor.

A more sophisticated version of the IMRT is the Tomo Therapy system. This process which is already commercially patented, implements Computer Tomography guided IMRT technology that allows focusing the radiation source completely around the cancer patient. This enables the Linac radiotherapy beam to easily create and focus on a three dimensional contour of the tumor. Tomo therapy is considered relatively new since it has just been clinically applied in 2003.

The most recent development of scanning technology in conjunction with radiotherapy is the Image Guided Radiation Treatment (IGRT) system. The unique feature of the IGRT machine is that it implements dynamic Computer Tomography images of the body to compensate and pinpoint any mobility the tumor has experienced. This somewhat solves the problem of targeting and scanning tumors inside the body since it is normally mobile. Amazingly, IGRT technology refocuses every degree of movement enabling a more accurate method to target the tumor. Basically, IGRT is considered the most versatile and sophisticated form of radiotherapy.

For patients planning to undergo radiotherapy, it is wise to consult to your physician of the various methods of radiotherapy available. Patients must also consider the costs and benefits of each method.

When dealing with the treatment of prostate cancer, several methods come to mind. Usually, various different treatment methods are combined to achieve the most optimal results. One treatment method for prostate cancer is Brachytherapy. This is a form of treatment where several radiation seeds are inserted into the cancerous tumor located in the prostate gland. Subsequently, the inserted seeds produce a dose of radiation into the tumor over a certain time frame which can be several months depending on the stage of the cancer.

Even though brachytherapy has the same principal as conventional radiotherapy, the way it is administered is quite different. The basic mechanism of both methods is to apply radiation to eradicate cancerous cells. With brachytherapy, radiation seeds supply the dosage of radiation need to eradicate the cancer. With this method, radiation exposure levels are not damaging to other parts of the body, but it can still cause short term and long term side effects. A majority of brachytherapy side effects are similar to conventional radiotherapy but there are slight differences.

Several short term side effects for prostate cancer radiotherapy include tiredness, pubic hair loss, diarrhea and cystitis which can cause pain during urination. As for the long term side effects of prostate cancer radiotherapy include urinary incontinence and difficulties or inability to have an erection. On the other hand, brachytherapy is less likely to cause urinary incontinence compared to conventional radiotherapy.

Several studies have claimed that even with adequate chemotherapy there is an estimated 33% likelihood that the cancer may recur sometime in the future even after it has be eradicated by radiation.

Radiotherapy is usually combined with hormonal therapy to accomplish the most beneficial results. Often before undergoing radiotherapy, the physician will administer hormonal therapy which inhibits testosterone needed by the cancer to develop. Basically, it all comes down to the preference of the patient as to which type of treatment they would like to undergo but their physician will surely recommend the most adequate and beneficial course of treatment.

Even though radiotherapy is a standard treatment for most types of cancer, there are quite a few patients suffering from breast cancer that question the need for it after surgical removal of breast cancer tissues. It is a fact that around 30% of women that do not undergo radiotherapy experience cancer recurrence, even though they have gone through surgery to remove the cancerous tumor from their breast. Physicians often find it quite difficult to differentiate the healthy tissue around the cancer since it is somewhat complicated in measuring with detail the amounts of cancer cells. There is a possibility that there might be skip areas between cancerous tissues and tiny difficult to find satellite cancer tumors surrounding the area. It is also possible for cancer cells to travel via the breast duct system and develop outside the location of biopsy. Radiotherapy is very beneficial since it has a better likelihood of eradicating those random cancer cells developing outside the main breast cancer areas.

Radiotherapy is basically a cancer treatment that uses a specific machine called a linear accelerator. This machine transforms radioactive particles into beams of high energy radiation which is applied to specific areas of the body. When a specific tissue area is exposed to these radiation beams, the dividing cells in the cancerous areas are influenced more compared to resting normal cells. Subsequently, cancerous cells are more affected by radiation than healthy cells even though both types of cells experience radiation damage. Factually, normal healthy cells are more capable for self repair after being exposed to radiation compared to cancerous cells. Exposure to radiation causes cancerous cells to enter the cell death cycle or also known as apoptosis during the following cell division.

Physicians may recommend radiotherapy focused on areas of the chest after breast surgery or mastectomy if the breast cancer has infiltrated the surgical margins or if the cancer has metastasized into the lymph nodes. Administering radiotherapy increases the survival rate and significantly decreases the recurrence rate.

It is quite difficult to decide if radiotherapy is always needed to treat breast cancer. This is because that the type of cancer therapy varies from patient to patient and multiple factors influence the final therapeutic approaches. These factors include the stage of the cancer, the overall wellness of the patient, the radiotherapy technology available and many more. For smaller cancer lesions with a wide apparent margin of healthy tissue without metastasis to the local lymph nodes, radiotherapy may not be required particularly if the patient has large deposits of fat tissues in the breasts. The older a woman becomes the increase of fatty tissue to glandular tissue occurs, particularly in the breast. It is rather usual for a woman’s breasts to have major amounts of fatty tissue which isn’t essentially correlated to obesity. As a matter of fact, skinny women may a have a large percentage of fatty tissue in their breasts. Subsequently, the amount of fat in the breasts can be a factor in deciding if radiotherapy is required or not post mastectomy.

Just like any other treatment modality, several side effects can occur with radiotherapy. The most common side effects are changes to the skin around the breasts, with manifestations such inflammation and redness which often eventually heals naturally. About ninety percent of women experience amazing cosmetic outcomes when the lesions heal. On the other hand, ten percent of women suffer from breast shrinkage, fibrous tissue development, decrease skin sensitivity and skin elasticity in the affected area of the breast. It is wise to consult a physician on the management to treat the long term side effects of radiotherapy to ensure a better quality of life.

Radiation therapy or also known as radiotherapy is regularly used to treat cancer. Currently, along with surgery and chemotherapy, radiotherapy is a standard treatment protocol for various types of cancer. Though, compared to other types of treatment modalities such as surgery and chemotherapy, radiotherapy has the least amount of knowledge and understanding by a majority of the public. Basically, there are four variations or types of radiotherapy which are explained below.

First of all is the conventional and conformal therapy, this procedure is usually administered to simple and basic cancer cases. This technique uses single or double beam directions to irradiate a specific target area without the use of intricate shielding areas of the body that has not been affected by the cancer such as the spine or brain. The basic principal for this procedure is applying multiple radiation beam directions to focus as close as possible towards the target are subsequently delivering enough radiation dosage to the cancer area and simultaneously limit radiation exposure to healthy tissues close by. Three dimension anatomic data of the patient is essential for both conventional and conformal therapy techniques in order to obtain close distributions of the cancer area.

The following radiotherapy technique is Intensity Modulated Radiation Therapy or IMRT for short. Currently, it is the most sophisticated radiotherapy technology available. This technique allows non uniform radiation beams to be irradiated onto the patient from any position of the radiation source thus optimizes radiation distribution in a composite dosage. Basically, the result of IMRT therapy is quite more significant compared to other radiotherapy techniques since it limits the exposure of healthy organs and tissue to radiotherapy exposure. This technique allows higher doses of radiations to be focused on the cancer cells without enhancing the side effects of radiation exposure. Subsequently, this increases the survival rate post cancer therapy.

The next technique of radiotherapy is stereotactic radiosurgery or commonly called SRS in medical circles. Basically, contradictive to its name, SRS is a non surgical technique which applies intensively focused radiation beams to cure various types of cancer and lesions that are considered inoperable. It can also be used post operatively to eradicate any remaining cancer cells and tissue or in congenital arteriovenous malformations to destroy abnormal blood vessels. One important factor for this method of radiotherapy is that it requires an exact treatment setup with intense accuracy including computerized therapy planning and specific imaging. Basically this method of treatment is administered only once or a few times depending on the dosage required by the oncologist.

Finally, Image Guided Radiation Therapy or IGRT is another technique for radiotherapy. This technique is also quite accurate in administering radiotherapy treatment. We all know that the body is unique which constantly is mobile subsequently this mobility affects the nature of our organs. With the mobility of organs, it is quite logical that the cancer or tumor can also become mobile in between radiotherapy sessions. Basically, IGRT is a technique based on real time imaging where an image of the cancer patient is obtained to be matched up to the planning image before undergoing therapy.

Although the different techniques of radiotherapy may sound complicated and confusing, it is important for patients planning to undergo radiotherapy to understand the type of radiotherapy the will experience. For more information it is important to consult your physician especially an oncologist.

Alternative cancer treatments also called complementary treatments are non-traditional methods of diagnosing, preventing, or treating cancer. A good amount of cancer patients find these therapies as good alternatives to relieve side effects or symptoms, ease pain, and make their lives more comfortable during treatment.

Mind, body, and spirit alternative cancer treatments are non-traditional methods that promote optimistic attitude and a healthy spirit to give positive physical results. Mind-body medicine is founded on an area of care, Psychoneuroimmunology (PNI). It is the study of how the mind affects the body. Psycho, being the patient’s state of thinking, mood, and emotions while Neuro, being the neurological and neuroendocrine systems of the body. Immunology pertains to the patient’s cellular structure and immune system.

The spiritual well being is another important aspect of alternative cancer treatments as it is said to be an important part of daily life many cancer patients and may be a vital part that lets them cope with cancer and its treatments. Some cancer centers give importance to spiritual or pastoral care teams that provide spiritual support for patients and their family members where patients may include spiritual counseling as part of a comprehensive treatment plan.

Oncology rehabilitation or “manual healing and physical touch” alternative cancer treatments include non-traditional therapy that covers, but is not limited to, physical therapy, occupational therapy, speech-language pathology, acupuncture, and reflexology. Physical therapy aims to improve the patient’s quality of life and independence by improving physical activity and comfort. Occupational therapy is geared toward assisting and training patients to perform daily activities as independently as possible. Speech-language pathology helps patients relay their wants and needs clearly and easily, it also assists in eating and swallowing. Acupuncture is a form of Chinese medicine that uses sterile needles applied to areas of the body called “acupoints” which stimulates energy flow or “chi”. Reflexology is a treatment which uses pressure applied to specific areas of the feet or hands aiming to relieve various problems and balance flow of vital energy throughout the body. Other therapies under oncology rehabilitation are electromagnetic therapy, heat therapy, light therapy, magnetic therapy, neural therapy, etc.

Herbs, vitamins, and minerals are used as alternative cancer treatments used in naturopathic medicine. It refers to the use of nature’s healing power to maintain and restore health. Naturopathic practitioners specialize in natural health care with the use of therapeutic nutrition, botanical medicine, homeopathy, hydrotherapy, and more to support holistic being, with emphasis on building health.

Nutrition Therapy is another alternative cancer treatment that focuses on diet and nutrition. Such therapy may include fasting, juicing, and other dietary practices. Nourishing the body with healthy, well-balanced diets is a way to help in the fight against cancer. Prevention of malnutrition and provision of adequate nutrition is essential during the treatment period. Nutrition therapy may be integrated into a comprehensive cancer healthcare plan. Personalized nutrition plans are designed to keep patients nourished, relieve side effects, and enhance overall well-being and quality living.

Pharmacological and biological treatment are alternative cancer treatments aimed to slow or stop the growth of cancer cells which may involve any of, but not limited to, the following: antineoplaston therapy, cell therapy, chelation therapy, di bella therapy, enzyme therapy, immune-augmentative therapy.

Pain management programs are alternative cancer treatments aimed to address common pain problems among cancer patients. As the treatment methods are expected to have side effects on patients including pain, pain management can reduce discomfort which can give patients better quality of life.

Among all other diseases, the most common disease that makes a number of women to suffer these days is the breast cancer. Not only that it makes women suffer but it is also increasing the number of womens death rate yearly. Because of this increasing rate, people who are experts when it comes to medicine have developed a lot of ways to examine if they have early stages of cancer to prevent it.

Aside from breast cancer examination, experts in the medical field tries to develop new treatment methods in order to help lower down womens death rate because of breast cancer. For more than several years, lumpectomies and mastectomies have been the undisputable way of treating cancer. However, they can have their own benefits and also disadvantages for women. As an example, lumpectomy will still need to require several days or weeks of post-operative treatments or procedures through radiation or therapy. Mastectomy on the other hand, has several complications during the operation.

But new treatments for breast cancer are already available in the market these days because of the advancement of medical sciences. Medicines have been developed in order to keep women safe from potential hazard from breast cancer.

The first drug is Abraxane. This is being used for chemotherapy and is considered to be more effective than the others. The medicines used for chemotherapies in the past are having some problems being diluted in water. Because of this, they should be given to the patients in the form of solvent which increases the side effects such as rashes and others. With this, the patient will be able to continue with the medication and get treated with cancer.

The next medicine is going to take care of the genes itself called Herceptin. One of the main reasons why breast cancer is growing is because of genes that are making breast cancer cells grow uncontrollably. This medicine can be incorporated with chemotherapy or not have proven that they have been a good help for women who have cancer because they have controlled the gene and thus stopping the multiplication of cancer cells.

Radiation therapy is also available for women who are suffering from breast cancer. They are offering precise treatments for patients by targeting down the cancer cell and prevent them from growing. However, even though it is a very precise process of eliminating the cancer cells, it is undeniable that even normal cells can also be affected and damaged. There are also other medicines that can be optional inclusion for chemotherapies. In this way, you will definitely increase the chances of the cancer cells to be treated totally.

Because of these treatment options, the patients need not despair about getting treatment. They can just go ahead with it in order to stop the growth of the cancer cells and thus increase the survival rates of the patients. And with all the new technology, it will be possible that new treatments will then again be developed for the benefits of the patients surviving this disease.

Two types of lung cancer are small cell lung cancers (SCLC) and non-small cell lung cancers (NSCLC). Non-small cell lung cancers are more often diagnosed. About 80 percent of lung cancer cases account to non-small cell lung cancers. They are divided into three types: adenocarcinomas, squamous cell carcinomas, and large cell carcinomas. Small cell lung cancers arise in the lung tissue. They spread more rapidly than most non-small cell lung cancers. About 20 percent of lung cancers account to small cell lung cancer.

Prognostic factors in non-small cell lung cancer include the presence of pulmonary symptoms, cancer size, histology, staging, the extent of metastases, and vascular invasion. Patients who are considered inoperable, have lower lung cancer survival rate. Such prognostic factors include performance status, gender, cancer stage, and involvement of the central nervous system (liver) upon diagnosis. Prognosis for non-small cell lung carcinoma is generally poor.

Prognostic factors in small cell lung carcinoma depend on the stage defined as limited (cancer is found in one lung, tissues in between lungs, and nearby lymph nodes) or extensive (metastasis). The prognosis is also generally poor with an overall lung cancer survival rate of 5 percent. Patients diagnosed with extensive stage have a survival rate of less than 1 percent.

Lung cancer is usually diagnosed during a stage when it has already spread to other parts of the body which is why the chances of survival are low. Lung cancer survival rates depend on the type of lung cancer, stage, and the general physical well-being of the patient. Due to the advancements in research and medical practices, the survival rates are slowly but steadily increasing over time.

Survival rates, however, are not accurate measures to be used in any individual case. Only medical practitioners looking into particular cancer conditions can define or estimate the survival rate of a lung cancer patient.

For limited stage small cell lung cancer, the lung cancer survival rate ranges from 15 to 25 percent. In this stage, the cancer is limited to one of the lungs, the mediastinum, and adjacent lymph nodes. Early diagnosis may indicate that the cancer is only limited and may be partly cured by radiation and chemotherapy. Nevertheless, only 20 to 30 percent are diagnosed early.

For extended stage small cell lung cancer, the lung cancer survival rate ranges from 0 to 2 percent. Because most of small cell lung cancers are detected when proliferation has traveled to other body parts, the focus is directed to palliative care.

For stage 0 non-small cell, the lung cancer survival rate ranges from 70 to 80 percent. Diagnosis in the earliest stage indicates that the cancer is confined to a specific area and in the first few layers of the cells. At this point, it may be cured and the survival rate is high.

For stage I non-small cell, the lung cancer survival rate is 50 percent. The cancerous cells are already manifested in the lungs and the normal tissue around them. However, lung cancer is still considered localized and can be surgically removed.

For stage II non-small cell, the lung cancer survival rate is 30 percent. The cancerous cells have already invaded the lymph nodes adjacent to the lungs. The roots of the cancer are moderately spread and results to a decline in the survival chance.

For stage III non-small cell, the lung cancer survival rate ranges from 5 to 20 percent. This stage indicates wide spread of the cancerous cells. Invasion is evident in the chest wall, diaphragm, and nearby organs and blood vessels. Possible metastases may be found in mediastinum.

For stage IV non-small cell, the lung cancer survival rate is less than 2 percent. The metastases have spread to distant organs through the blood and the chances of survival drop to a very low level.

Liver cancer refers to malignant growths that arise in the liver. Cancer cells found in the liver that originated in another organ are called liver metastases. The liver is found below the right lung and under the ribcage. It is divided into two lobes: the right and the left. The liver obtains protein from the portal vein. The portal vein carries nutrient-rich blood from the intestines to the liver. The hepatic artery provides oxygen-rich blood to the liver.

Cancers that start in the liver are hepatocellular carcinoma (HCC), hepatoblastoma, cholangiocarcinoma, and angiosarcoma and hemangiosarcoma. Hepatocellular carcinoma, normally diagnosed among younger individuals, contains variations of HCC and cholangiocarcinoma. Hepatoblastoma, normally diagnosed among children, is mostly a tumor form in the right lobe that can spread to other parts of the body. Cholangiocarcinoma or bile duct cancer start in the small tubes (bile ducts) that carry bile to the gallbladder. Angiosarcoma and hemangiosarcoma are rare forms of cancer that arise in the blood vessels which grow quickly and by the time they are found, they are too widespread to be removed making patients live shorter than a year in most cases.

The treatment of liver cancer may present the difference between life and death. Some of the treatments available are surgery, chemotherapy, immunotherapy, photodynamic therapy, hyperthermia, radiation therapy, and radiosurgery.

Liver Cancer Prognosis depends on many variables like the extent of the cancer, metastases, general physical health, and the impact on the liver. Treatment centers are aimed towards improving liver cancer prognosis and the patients’ health and quality living.

There are diagnostic techniques that help physicians determine the progression or stage of the disease. A more accurate liver cancer prognosis results to a treatment plan that will best address the needs of the individual. The American Joint Committee on Cancer’s TNM system is used to aid in liver cancer staging. Such system defines the size and location of the tumor, invasion of the regional lymph nodes, and extent of the liver cancer metastasis.

“T Staging” determines the tumor count. T1 means there is no invasion caused by a single tumor. T2 means the single tumor invaded blood vessels. T2 also refers to multiple tumors smaller than a diameter of 5cm. T3 means multiple tumors are greater than 5cm in diameter. T3 also refers to a tumor affecting a major blood vessel. T4 is the invasion of a nearly organ apart from the gallbladder. T4 also refers to a tumor invasion of the liver’s covering or visceral peritoneum.

“N Staging” determines tumor location based on region. NX means the regional lymph nodes cannot be assessed. N0 means the cancer has not metastasized to regional lymph nodes. N1 means the cancer has reached regional lymph nodes.

“M Staging” determines the tumor location based on the distance reached from the primary location. MX means distant metastasis cannot be assessed. M0 means the cancer has not metastasized to other distant organs or lymph nodes. M1 means the cancer has metastasized to distant organs or lymph nodes, or both.

TNM stages are combined into the generally used Roman numeral staging from 0 to IV where the greater the stage, the more advanced and dangerous the disease.

Non-small cell lung cancers are grouped together because they display similar prognosis and management options. These sub-types are adenocarcinoma lung cancer, squamous cell lung cancer, and large cell lung cancer.

Adenocarcinoma is a cancer that arises in a glandular tissue. The tissue is also part of a larger category, the epithelial. Adenocarcinomas, do not have to be part of the gland. As long as they have secretory properties, they can be classified as adenocarcinomas. Such form of carcinoma occurs in few higher mammals including man. Through biopsy, a pathologist determines if the tumor is an adenocarcinoma or another type of cancer. Adenocarcinoma can originate in many tissues of the body. Each gland does not secrete the same substance but for as long as there is an exocrine function to the cell, it is considered glandular. A malignant form therein is named “adenocarcinoma”. Abnormal tissue that is considered benign (not malignant) is called “adenoma”. Adenomas typically do not invade other tissues and rarely spread or metastasize as opposed to adenocarcinomas that invade other tissues and metastasize.

Adenocarcinoma lung cancer is the most common type of lung cancer in patients who have never smoked all their lives. It accounts to about 10 percent of lung cancers. Unlike small cell and squamous cell lung cancer, this cancer is commonly seen peripherally in the lungs. Smokers may also be diagnosed in smokers but not as usual as it would be found in non-smokers. In a biopsy, adenocarcinoma lung cancer tends to stain musin positive as it is derived from the lung glands that produce mucus. Well differentiated adenocarcinoma lung cancer resembles the normal glandular structure. Poorly differentiated adenocarcinoma lung cancer doesn’t resemble the normal glands.

A number of factors including the extent of the disease, general health condition, and metastases help determine the most appropriate cancer treatment combinations.

Conventional treatment options may be used to treat adenocarcinoma lung cancer. Surgery, radiation and chemotherapy are three common forms of cancer treatment that have been used for many years. For certain types of cancer cases, surgery is the most common way to remove tumor growths. Radiation therapy, which involves the use of high energy rays to kill or impede tumor growth, may be used in combination with other forms of cancer treatment. It is also an alternative when surgery cannot be an option. Chemotherapy uses drugs to kill or slow the growth of malignancies. It is often paired with other forms of cancer treatment. Doctors control how chemotherapy is administered to manage dosage allowing the patient to tolerate the side effects that are expected.

Immunotherapy or biotherapy, a less common treatment for adenocarcinoma lung cancer, uses the body’s immune system to fight the cancer or reduce the side effects of therapies. A physician can assess a particular cancer case and see if it may be an appropriate course of treatment for a patient.

In addition to a number of advanced conventional treatment options, alternative or complementary treatment for adenocarcinoma lung cancer may be available. These non-conventional are designed to create personalized treatment plans that help patients focus on healing. Examples of these therapies are geared toward nutrition, pain management, naturopathy, spiritual, mind-body, etc.